Dermata Therapeutics
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2014-01-01
- Employees
- 8
- Market Cap
- -
- Website
- http://www.dermatarx.com
- Introduction
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
DMT310-009 Topical in the Treatment of Acne Vulgaris
- Conditions
- Acne Vulgaris
- Interventions
- Drug: DMT310Drug: Placebo
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2023-12-21
- Lead Sponsor
- Dermata Therapeutics
- Target Recruit Count
- 555
- Registration Number
- NCT06090721
- Locations
- 🇺🇸
Center for Dermatology Clinical Research, Inc., Fremont, California, United States
🇺🇸DermResearch, Austin, Texas, United States
DMT310-005 Topical in the Treatment of Acne Rosacea
- Conditions
- Acne Rosacea
- Interventions
- Drug: Placebo Topical PowderDrug: Topical Powder
- First Posted Date
- 2021-11-04
- Last Posted Date
- 2022-12-08
- Lead Sponsor
- Dermata Therapeutics
- Target Recruit Count
- 180
- Registration Number
- NCT05108025
- Locations
- 🇺🇸
Dermata Investigational Site, Austin, Texas, United States
DMT310-003 Topical in the Treatment of Acne Vulgaris
- Conditions
- Acne Vulgaris
- Interventions
- Drug: DMT310Drug: Placebo
- First Posted Date
- 2019-09-27
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- Dermata Therapeutics
- Target Recruit Count
- 181
- Registration Number
- NCT04106778
- Locations
- 🇺🇸
Dermata Investigational Site, Austin, Texas, United States
DMT310-001 Topical in the Treatment of Acne Vulgaris
- Conditions
- Acne Vulgaris
- Interventions
- First Posted Date
- 2018-05-25
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- Dermata Therapeutics
- Target Recruit Count
- 121
- Registration Number
- NCT03536637
- Locations
- 🇺🇸
Dermata Investigational Site, Katy, Texas, United States
DMT210 Topical Gel in the Treatment of Acne Rosacea
- Conditions
- Acne Rosacea
- Interventions
- Drug: DMT210 Topical Gel 5%Other: Vehicle Control
- First Posted Date
- 2016-12-26
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Dermata Therapeutics
- Target Recruit Count
- 107
- Registration Number
- NCT03003104
- Locations
- 🇺🇸
Dermata Investigational Site, Norfolk, Virginia, United States
DMT210 Topical Gel in the Treatment of Atopic Dermatitis
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: DMT210 Topical GelDrug: Vehicle Control
- First Posted Date
- 2016-10-31
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Dermata Therapeutics
- Target Recruit Count
- 19
- Registration Number
- NCT02949960
- Locations
- 🇺🇸
Dermata Investigational Site, Norfolk, Virginia, United States